Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fischer Medical Ventures Limited is a prominent Indian medical technology company that has achieved a significant milestone as the first indigenous manufacturer of high-quality Magnetic Resonance Imaging (MRI) systems in India. Headquartered in Chennai, the company has strategically expanded its focus beyond medical imaging into advanced diagnostics and AI-driven drug discovery through its associate company, Nanyang Biologics (NYB). Utilizing the VECURA AI platform, the company aims to accelerate the discovery of natural therapeutic compounds and has developed a pipeline of science-backed nutraceuticals, such as the longevity-focused CareViva NS. Fischer Medical Ventures also operates in the digital health space through its subsidiary DigiHealth, which provides automated telehealth machines for rapid primary care screening in underserved regions. The company is publicly traded on the National Stock Exchange of India (NSE) and the Bombay Stock Exchange (BSE).
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Medical Ventures.